Approvals/TGA/VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension for injection in pre-filled syringe needle free 2025 Season

Approved

STANDARD

VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension for injection in pre-filled syringe needle free 2025 Season

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: 65b43623c7d2263a
Company: Sanofi-Aventis Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 65b43623c7d2263a
Product Name: VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension for injection in pre-filled syringe needle free 2025 Season
Artg Id: 299922
Artg Name: VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus HA 60 mcg 0.5 mL suspension for injection PFS needle free
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2019-05-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/8c9b3de3d34dea6308c43e904f810b33.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/fc96d2d6965ac8af021813d463ed766a.pdf

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

65b43623c7d2263a

Type

Standard

Back to TGA Approvals